Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02690064 · ClinicalTrials.gov registry record · NA
Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF
A NA study of Cystic Fibrosis, sponsored by Augusta University.
- Active
- Registry status
- NA
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT02690064 is a NA study of Cystic Fibrosis that is active but no longer recruiting, run by Augusta University. The registered enrollment target is 13 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02690064, a NA study of Cystic Fibrosis, is active but no longer recruiting, sponsored by Augusta University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
Cystic fibrosis has many health consequences. A reduction in the ability to perform exercise in patients with CF is related to greater death rates, steeper decline in lung function, and more frequent lung infections. However, the physiological mechanisms for this reduced exercise capacity are unknown. The investigators recently published the first evidence of systemic vascular dysfunction in patients with CF. Therefore, it is reasonable to suspect that the blood vessels are involved with exercise intolerance in CF. This study will look at how and if oxidative stress contributes to both artery dysfunction and exercise intolerance in CF.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Acute Antioxidant
- DIETARY_SUPPLEMENT Chronic Antioxidant
Study Locations (1)
Georgia
- Georgia Prevention Institute - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-04 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02690064
The ClinicalTrials.gov registry entry for NCT02690064 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (93% lower). The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02690064 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT02690064 about?
NCT02690064 is a clinical study titled "Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF". Cystic fibrosis has many health consequences. A reduction in the ability to perform exercise in patients with CF is related to greater death rates, steeper decline in lung function, and more frequent lung infections. However, the physiological mechanisms for this reduced exercise capacity are unknow...
What is the current status of trial NCT02690064?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 13 participants. The study started on 2015-04. Estimated completion is 2027-01.
What conditions does trial NCT02690064 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT02690064?
The interventions under investigation include: Placebo (OTHER), Acute Antioxidant (DIETARY_SUPPLEMENT), Chronic Antioxidant (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02690064?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02690064 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
FEED-Cystic Fibrosis (FEED-CF)
RECRUITING · NA
-
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
RECRUITING · NA
-
Skin-interfaced Colorimetric Bifluidic Sweat Sensor Device for the Diagnosis of Cystic Fibrosis (CF)
RECRUITING · NA
-
Lung Transplant READY CF 2: CARING CF Ancillary RCT
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.